MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Sales Lead, Hepatology Business Unit, will lead a highly specialized field team of Regional Account Managers (RAMs) in Germany. This role is responsible for advancing disease awareness, supporting account performance, and helping to establish appropriate patient identification, referral, and management pathways in areas of profound unmet need. This role contributes to Mirum’s mission by helping improve awareness, access and support for people living with rare liver diseases in Germany. This leader must excel at operating in ambiguity—defining strategy, building structure, and driving execution in a market that is still being shaped in real time.
JOB FUNCTIONS/RESPONSIBILITIES
Strategic Leadership
- Build and lead the Hepatology sales team of Regional Account Managers across key German geographies
- Develop and execute commercial plans for current hepatology priorities and support market development for future opportunities in rare liver diseases
- Prioritize relevant specialist networks, regional opportunities and key accounts to support effective field execution
- Translate market and field insights into actionable strategies that support launch readiness, post-launch execution and clear commercial priorities
- Build structure in emerging market environments by setting direction, establishing priorities and adapting strategy as new information becomes available
Market Development & Disease Education
- Support disease awareness and patient identification in rare liver diseases with high unmet need
- Partner with specialist centers, KOLs and relevant institutions to support appropriate diagnosis, referral and treatment pathways
- Support the field team in identifying local implementation needs and opportunities to improve patient pathway
- Account Engagement & Activation
- Ensure strategic engagement across expert centers, key stakeholders and relevant regional health-system networks
- Coach RAMs to develop account plans that reflect local stakeholder needs, care pathways and execution priorities
- Represent the field perspective in cross-functional planning with Medical Affairs, Market Access and Marketing to shape aligned execution
- Support accounts in navigating complex and evolving care environments
Team Leadership & Development
- Recruit, develop and coach a high-impact team of RAMs through structured field coaching, feedback, workshops and best-practice exchange
- Set clear expectations aligned with approved commercial and medical objectives and coach the team to make proactive, compliant decisions in dynamic field environments
- Foster a culture of accountability, agility, shared ownership and mission-driven execution, grounded in Mirum’s values of care, authenticity, results orientation and positive collaboration
- Lead both directly and through influence, creating alignment across RAMs, cross-functional partners and commercial leadership
- Establish consistent field execution standards while encouraging local ownership and entrepreneurial problem-solving
Cross-Functional Collaboration
- Serve as the field leadership voice in commercial planning and execution, aligning stakeholders around evolving priorities while ensuring compliant field activities
- Partner closely with:
- Medical Affairs on scientific exchange and KOL engagement
- Marketing on brand strategy, field needs and key tactics
- Commercial leadership on business planning and execution
QUALIFICATIONS
Education/Experience:
- Master’s degree in science required
- 10+ years of pharmaceutical/biotech experience, including 5+ years of field experience
- Proven experience in rare disease and/or specialty care, ideally including hepatology or highly specialized care environments
- Demonstrated track record of shaping launch, growth or market-development strategies in complex healthcare environments
- Strong understanding of the German healthcare system, academic centers, specialist networks and regional access dynamics
- Strong KOL engagement and scientific fluency in complex, science-driven specialty markets
- Thrives in a fast-paced, dynamic and collaborative environment
- Able to travel frequently, including up to 70% overnight travel, and hold a valid driver’s license
- Combines strategic thinking with hands-on field execution, clear prioritization and disciplined follow-through
- High emotional intelligence, facilitation skills and stakeholder influence across peers, leadership and cross-functional groups
- Ability to understand and communicate scientific information effectively within role, scope and compliance boundaries
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- Master's degree in science
- 10+ years pharmaceutical/biotech experience, including 5+ years field experience
- Proven experience in rare disease and/or specialty care (ideally hepatology)
- Track record shaping launch, growth or market-development strategies in complex healthcare environments
- Strong understanding of the German healthcare system, academic centers, specialist networks and regional access dynamics
- Strong KOL engagement and scientific fluency in complex, science-driven specialty markets
- Ability to travel frequently, up to 70% overnight, and hold a valid driver's license
- Experience recruiting, developing and coaching field teams with structured coaching and performance management
- High emotional intelligence, facilitation skills and stakeholder influence
- Ability to understand and communicate scientific information effectively within compliance boundaries
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
